124 related articles for article (PubMed ID: 37271453)
1. Genomic features of recombinant CHO clones arising from transposon-based and randomized integration.
Huhn SC; Chang M; Jiang B; Tang X; Betenbaugh M; Du Z
J Biotechnol; 2023 Aug; 373():73-81. PubMed ID: 37271453
[TBL] [Abstract][Full Text] [Related]
2. Recombinant CHO Cell Pool Generation Using PiggyBac Transposon System.
Balasubramanian S
Methods Mol Biol; 2024; 2810():137-146. PubMed ID: 38926277
[TBL] [Abstract][Full Text] [Related]
3. Recombinant CHO Cell Pool Generation Using piggyBac Transposon System.
Balasubramanian S
Methods Mol Biol; 2018; 1850():69-78. PubMed ID: 30242681
[TBL] [Abstract][Full Text] [Related]
4. Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase.
Tschorn N; van Heuvel Y; Stitz J
Mol Biotechnol; 2023 Aug; 65(8):1327-1335. PubMed ID: 36547824
[TBL] [Abstract][Full Text] [Related]
5. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
6. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability.
Matasci M; Baldi L; Hacker DL; Wurm FM
Biotechnol Bioeng; 2011 Sep; 108(9):2141-50. PubMed ID: 21495018
[TBL] [Abstract][Full Text] [Related]
7. Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines.
Rajendran S; Balasubramanian S; Webster L; Lee M; Vavilala D; Kulikov N; Choi J; Tang C; Hunter M; Wang R; Kaur H; Karunakaran S; Sitaraman V; Minshull J; Boldog F
Biotechnol Bioeng; 2021 Jun; 118(6):2301-2311. PubMed ID: 33704772
[TBL] [Abstract][Full Text] [Related]
8. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Huang X; Haley K; Wong M; Guo H; Lu C; Wilber A; Zhou X
Hum Gene Ther; 2010 Nov; 21(11):1577-90. PubMed ID: 20528476
[TBL] [Abstract][Full Text] [Related]
9. Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools.
Balasubramanian S; Matasci M; Kadlecova Z; Baldi L; Hacker DL; Wurm FM
J Biotechnol; 2015 Apr; 200():61-9. PubMed ID: 25758242
[TBL] [Abstract][Full Text] [Related]
10. Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System.
Balasubramanian S; Peery RB; Minshull J; Lee M; White R; Kelly RM; Barnard GC
Biotechnol J; 2018 Oct; 13(10):e1700748. PubMed ID: 29797786
[TBL] [Abstract][Full Text] [Related]
11. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of Sleeping Beauty transposon integration in human somatic cells.
Turchiano G; Latella MC; Gogol-Döring A; Cattoglio C; Mavilio F; Izsvák Z; Ivics Z; Recchia A
PLoS One; 2014; 9(11):e112712. PubMed ID: 25390293
[TBL] [Abstract][Full Text] [Related]
13. Concurrent transfection of randomized transgene configurations into targeted integration CHO host is an advantageous and cost-effective method for expression of complex molecules.
Dong E; Lam C; Tang D; Louie S; Yim M; Williams AJ; Sawyer W; Yip S; Carver J; AlBarakat A; Tsukuda J; Snedecor B; Misaghi S
Biotechnol J; 2021 Apr; 16(4):e2000230. PubMed ID: 33259700
[TBL] [Abstract][Full Text] [Related]
14. Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones.
Harris JW; Strong DD; Amoui M; Baylink DJ; Lau KH
Anal Biochem; 2002 Nov; 310(1):15-26. PubMed ID: 12413468
[TBL] [Abstract][Full Text] [Related]
15. Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools.
Rajendra Y; Balasubramanian S; Peery RB; Swartling JR; McCracken NA; Norris DL; Frye CC; Barnard GC
Biotechnol Prog; 2017 Mar; 33(2):534-540. PubMed ID: 28188692
[TBL] [Abstract][Full Text] [Related]
16. PiggyBac transposase and transposon derivatives for gene transfer targeting the ribosomal DNA loci of CHO cells.
Bire S; Dusserre Y; Bigot Y; Mermod N
J Biotechnol; 2021 Nov; 341():103-112. PubMed ID: 34560160
[TBL] [Abstract][Full Text] [Related]
17. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition.
Bire S; Gosset D; Jégot G; Midoux P; Pichon C; Rouleux-Bonnin F
BMC Biotechnol; 2013 Sep; 13():75. PubMed ID: 24070093
[TBL] [Abstract][Full Text] [Related]
18. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
[TBL] [Abstract][Full Text] [Related]
19. A versatile, highly efficient, and potentially safer piggyBac transposon system for mammalian genome manipulations.
Meir YJ; Lin A; Huang MF; Lin JR; Weirauch MT; Chou HC; Lin SJ; Wu SC
FASEB J; 2013 Nov; 27(11):4429-43. PubMed ID: 23896728
[TBL] [Abstract][Full Text] [Related]
20. Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system.
Ghanbari S; Bayat E; Azizi M; Fard-Esfahani P; Modarressi MH; Davami F
Appl Microbiol Biotechnol; 2023 Feb; 107(2-3):769-783. PubMed ID: 36536089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
